Find the investors funding Health rounds
326,000+ VC, angel and family-office profiles — direct emails, check sizes and stage filters.
Sweden’s Omnio raises €2.9 million to advance its plasminogen-based therapy for hard-to-heal chronic wounds - EU-Startups
Omnio is developing a plasminogen-based therapy for chronic wounds. This funding will advance their therapy for hard-to-heal wounds. The company is based in Sweden.
Sweden’s Omnio raises €2.9 million to advance its plasminogen-based therapy for hard-to-heal chronic wounds EU-Startups
| Oct 26, 2026 | Strawberry Agentic Browser | $6.0M | Seed | Sweden |
| Oct 19, 2026 | Vessla | $3.2M | — | Sweden |
| Oct 16, 2026 | Matters | $5.0M | Pre-seed | Sweden |
| Oct 08, 2026 | Yazen | $60.4M | Late-stage | Sweden |
You just read who funded Omnio. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.